Pliant Therapeutics Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
United States of America US
Employees
49
IPO date
Jun 3, 2020

Pliant Therapeutics is a biotechnology company that develops drug candidates for fibrotic diseases, where the body makes too much scar tissue in organs such as the lungs. Its main focus has been on medicines that block integrins, proteins that help drive the scarring process. The company is still in the drug-development stage, so it does not sell a commercial medicine yet.

Pliant’s work is aimed at patients with serious diseases like pulmonary fibrosis, along with the doctors and hospitals that run clinical trials for these treatments. The company spends most of its time and capital on research, testing, and clinical studies rather than manufacturing or selling products. If a candidate medicine succeeds, it could be sold directly or through a partner to physicians treating these patients.

The company makes money mainly through collaboration deals, licensing arrangements, and related research payments tied to its drug programs, with the longer-term goal of earning product sales or royalties if a medicine is approved. What makes its business different is that it is focused on a narrow but difficult class of diseases where the market depends on getting new drugs through years of testing and regulatory review before any commercial sales begin.

Pliant Therapeutics Inc Investor Relations

Address
331 Oyster Point Boulevard
South San Francisco, California
United States of America

Business Segments

Drug development

Pliant Therapeutics develops medicines that aim to treat fibrosis and other diseases that cause tissue scarring. The company runs its own research and clinical trials to move drug candidates forward, and it may also part...

Customers and revenue model

Management

Dr. Bernard Coulie M.B.A., M.D., Ph.D.

President, CEO & Director

Biography unavailable

Dr. Keith Lamont Cummings M.B.A., M.D.

Chief Financial Officer

Biography unavailable

Mr. Mike Ouimette J.D.

General Counsel & Corporate Secretary

Biography unavailable

Mr. Johannes P. Hull

Chief Business Officer

Biography unavailable

Dr. Eric A. Lefebvre M.D.

Chief Medical Officer

Biography unavailable

Mr. Hal Chapman M.D.

Scientific Founder & Member of Scientific Advisory Board

Biography unavailable

Mr. Craig D. Muir

Interim Chief Technology Officer

Biography unavailable

1 / 7